Fundraising Fox
hemostOD
Lausanne, CH · Founded 2020 · 12 employees on LinkedIn · 2 known investors
Find your way into hemostOD
Sign up to see every warm intro you have to hemostOD
- Paths you didn't know you had: your email and LinkedIn already hold routes to the hemostOD team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HemostOD engineers and manufactures universal (HLA-low) platelets using a proprietary platform that immortalizes hematopoietic progenitor cells and generates platelets via microfluidic bioreactors. The preclinical biotech targets applications in thrombocytopenia, tissue-targeted cargo delivery, regenerative medicine, and therapeutic stem cell culture.
Founders & leadership
hemostOD was founded in 2020 by Faouzi Khechana.
Investors · 2
Frequently asked questions
- What does hemostOD do?
- HemostOD engineers and manufactures universal (HLA-low) platelets using a proprietary platform that immortalizes hematopoietic progenitor cells and generates platelets via microfluidic bioreactors. The preclinical biotech targets applications in thrombocytopenia, tissue-targeted cargo delivery, regenerative medicine, and therapeutic stem cell culture.
- Who founded hemostOD?
- hemostOD was founded by Faouzi Khechana in 2020.
- Who are hemostOD's investors?
- hemostOD's investors include Polytech Ventures, Polytech Ecosystem Ventures.
- Where is hemostOD headquartered?
- hemostOD is headquartered in Lausanne, CH.